Abstract
Cognitive deficits are a fundamental feature of the psychopathology of schizophrenia. Yet the effect of treatment on this dimension of the illness has been unclear. Atypical antipsychotic medications have been reported to reduce the neurocognitive impairment associated with schizophrenia. However, studies of the pattern and degree of cognitive improvement with these compounds have been methodologically limited and have produced variable results, and few findings have been replicated. To clarify our understanding of the effects of atypical antipsychotic drugs on neurocognitive deficits in patients with schizophrenia, we have (1) reported on newly established standards for research design in studies of treatment effects on cognitive function in schizophrenia, (2) reviewed the literature on this topic and determined the extent to which 15 studies on the effect of atypical antipsychotics met these standards, (3) performed a meta-analysis of the 15 studies, which suggested general cognitive enhancement with atypical antipsychotics, and (4) described the pharmacological profile of these agents and considered the pharmacological basis for their effects on neurocognition. Finally, we suggest directions for the development of new therapeutic strategies.
Keywords
NeurocognitiveSchizophrenia (object-oriented programming)CognitionPsychopathologyAntipsychoticMeta-analysisPsychologyAtypical antipsychoticPsychiatryTypical antipsychoticClozapinePsychosisClinical psychologyMedicineInternal medicine
Affiliated Institutions
Related Publications
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Schizophrenia is one of the most common, burdensome, and costly psychiatric disorders in adults worldwide. Antipsychotic drugs are its treatment of choice, but there is controve...
Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis
Weight gain is a clinically important side effect of antipsychotic drug therapy. The aim of this study was to determine the effect of the antidiabetic drug metformin on antipsyc...
Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis
Abstract Objective To determine the accuracy of the Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression. Design Individual participant data meta-anal...
Context, cortex, and dopamine: A connectionist approach to behavior and biology in schizophrenia.
Connectionist models are used to explore the relationship between cognitive deficits and biological abnormalities in schizophrenia. Schizophrenic deficits in tasks that tap atte...
Extensive impact of non-antibiotic drugs on human gut bacteria
A few commonly used non-antibiotic drugs have recently been associated with changes in gut microbiome composition, but the extent of this phenomenon is unknown. Here, we screene...
Publication Info
- Year
- 1999
- Type
- review
- Volume
- 25
- Issue
- 2
- Pages
- 201-222
- Citations
- 692
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
692
OpenAlex
Cite This
Richard S.E. Keefe,
S. G. Silva,
Diana O. Perkins
et al.
(1999).
The Effects of Atypical Antipsychotic Drugs on Neurocognitive Impairment in Schizophrenia: A Review and Meta-analysis.
Schizophrenia Bulletin
, 25
(2)
, 201-222.
https://doi.org/10.1093/oxfordjournals.schbul.a033374
Identifiers
- DOI
- 10.1093/oxfordjournals.schbul.a033374